English | 简体中文 | 繁體中文 | 한국어 | 日本語
Sunday, 21 March 2021, 20:24 HKT/SGT
Share:
'Hi, Mom' Global Release on March 19 Salutes Motherhood Worldwide

HONG KONG, Mar 21, 2021 (ACN Newswire) - On March 19, the Chinese cinema hit 'Hi, Mom' started screening in 17 countries and regions around the world, including the US, Canada, the UK, Spain, China's special administrative regions of Hong Kong and Macau, New Zealand, Japan, South Korea, Singapore and Malaysia.

Best known as a 'hilarious tear-jerker', 'Hi, Mom' is a time-travel comedy that tells the story of motherhood and family affection. According to information from Maoyan Entertainment, China's leading platform providing innovative Internet-empowered entertainment services, the film was directed and starred by hugely popular Chinese comedian Jia Ling.

Since its premiere on the Chinese mainland during the Chinese New Year, the film has grossed RMB 5.3 billion (USD 814.3 million) at the box office, making it the second highest-grossing film of all time in the Chinese market, as well as one of the 100 highest-grossing titles in the world market.

Viewers who have watched the film say that what touches them most is how the film presents, in a happy, sincere way, the family affection of an ordinary person, something shared by all human beings. Many believe that 'Hi, Mom' is so emotionally stirring that it deserves to be a gift dedicated to all moms across the world.

A key opinion leader noted when speaking of 'Hi, Mom', "I think every story whether it's a science fiction story, or a contemporary drama, or something that took place in the 80s like 'Hi, Mom', or something that took place 2,000 years ago, it's all about people, and people relate to each other emotionally."


Topic: Press release summary Sectors: Media & Marketing, Broadcast, Film & Sat
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Six Tips for building a website that really works for your business  
Apr 17, 2024 10:30 HKT/SGT
ZOETIS (ZTS) Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Zoetis Inc. for Potential Securities Law Violations   
Apr 17, 2024 09:40 HKT/SGT
ZOETIS (ZTS): Kaplan Fox & Kilsheimer LLP Investigates Zoetis and Encourages Investors with Losses to Contact the Firm  
Apr 17, 2024 08:11 HKT/SGT
Elevating Possibilities: The Countdown for WBS Dubai Begins!  
Apr 16, 2024 23:33 HKT/SGT
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study  
Apr 16, 2024 21:10 HKT/SGT
InnoEX, Spring Electronics Fair boost tech hub status  
Apr 16, 2024 19:24 HKT/SGT
CleverTap bags ten prestigious awards at the 2024 Stevie Awards   
Apr 16, 2024 19:00 HKT/SGT
Lexus presents Time at the 2024 Milan Design Week  
Tuesday, April 16, 2024 5:49:00 PM
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy  
Apr 16, 2024 17:35 HKT/SGT
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology  
Apr 16, 2024 17:04 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575